Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 903
Recruiting: 504
Ph III recruiting: 46
Growth YoY: +21.9%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05634720	Hepatic Artery Chemotherapy for Patients With Localized Pancreas Cancer	active not recruiting	Phase 4	20	Duke UniversityOTHER	1	Jan 26, 2026	clinicaltrials
NCT04025840	Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery	active not recruiting	Phase 4	260	Peking University First HospitalOTHER	1	Jul 31, 2025	clinicaltrials